From: Inter-rater reliability of a national acute stroke register
N | Obs.agr. (%)a | Kappa (95 % CI) | AC1 (95 % CI) | |
---|---|---|---|---|
Discharge destination | ||||
Discharge destination | 111 | 74.8 | 0.69 (0.60–0.79) | 0.72 (0.63–0.81) |
Drug treatment at discharge | ||||
Aspirin (ASA) | 110 | 73.6 | 0.51 (0.38–0.64) | 0.65 (0.54–0.76) |
ADP receptor antagonist | 110 | 99.1 | 0.94 (0.83–1.00) | 0.99 (0.97–1.00) |
Dipyridamole | 110 | 71.0 | 0.25 (0.10–0.41) | 0.65 (0.53–0.76) |
Warfarin | 110 | 96.4 | 0.85 (0.70–0.99) | 0.96 (0.92–0.99) |
Diuretics | 110 | 88.2 | 0.60 (0.40–0.80) | 0.86 (0.79–0.94) |
ACE-inhibitor | 110 | 99.1 | 0.96 (0.90–1.00) | 0.99 (0.97–1.00) |
A2-receptor blocker | 110 | 93.6 | 0.75 (0.58–0.93) | 0.93 (0.87–0.98) |
Beta blocker | 110 | 94.5 | 0.87 (0.77–0.97) | 0.93 (0.88–0.99) |
Calcium channel blocker | 109 | 96.3 | 0.83 (0.66–0.99) | 0.96 (0.92–0.99) |
Statins | 110 | 96.4 | 0.93 (0.86–1.00) | 0.95 (0.93–1.00) |